One Kit, Complete Workflow: Standardized Mouse BMDM Differentiation and M1/M2 Polarization

Primary macrophages remain indispensable tools for studying innate immunity, inflammation, infection, cancer, and tissue repair. Among them, mouse bone marrow-derived macrophages (BMDMs) are widely regarded as the gold-standard in vitro model due to their physiological relevance, scalability, and compatibility with genetically modified mouse strains.

However, establishing reliable BMDM models is often challenging. Researchers frequently encounter issues such as inconsistent cytokine formulations, batch-to-batch variability, unstable differentiation efficiency, mixed polarization phenotypes, and poor experimental reproducibility.

 Figure 1. Differences between M1 and M2 macrophages^[1]

The Complete BMDM Cytokine Solution

To address these challenges, Yeasen introduces the Mouse Macrophage BMDM Cytokine Set (Cat#92643ES)—a standardized, all-in-one solution covering BMDM differentiation as well as M1 and M2 polarization.

• Maturation System (M-CSF): Generates mature, high-purity resting macrophages in just 7 days.
• M1 Polarization System (IFN-γ + LPS): Induces pro-inflammatory M1 macrophages for acute inflammation, infection, and anti-tumor studies.
• M2 Polarization System (IL-4 + IL-13): Induces anti-inflammatory M2 macrophages for tissue repair, fibrosis, and tumor microenvironment research.

No more optimizing cytokine combinations. No more repeating experiments to obtain consistent results.

Why Choose Yeasen's BMDM Cytokine Set?

• Literature-Validated Formulations

Optimized according to widely accepted experimental conditions reported in high-impact publications, eliminating the need for tedious cytokine optimization.

• Low Endotoxin, High Bioactivity

High-purity recombinant proteins minimize background activation and improve data reliability.

• Excellent Batch Consistency

Reduces variability commonly observed with self-prepared cytokine mixtures, enabling reproducible results across experiments.

• Free Experimental SOP Included

Comprehensive protocols covering: Bone marrow isolation→BMDM differentiation→Polarization schedules→

Experimental grouping strategies-→Marker validation methods

Even first-time users can rapidly establish robust macrophage models.

• Clear M1/M2 Phenotypes

Distinct polarization profiles facilitate downstream analyses and publication-quality data generation.

Experimental Principle

Mouse bone marrow progenitor cells are induced by M-CSF to differentiate into resting M0 macrophages (BMDMs). These cells can then be polarized into specific states:

M1 Polarization: LPS + IFN-γ activates the NF-κB pathway, driving cells toward a pro-inflammatory phenotype (marked by CD86).

M2 Polarization: IL-4 + IL-13 activates the JAK-STAT6 pathway, driving cells toward an anti-inflammatory, tissue-repair phenotype (marked by CD206).

 Figure 2. Principle of Macrophage Induction and Differentiation

Experimental Protocol

1. Mouse Bone Marrow Cell Extraction

1.1 Euthanize mice (6–8 weeks) via cervical dislocation and immerse in 75% ethanol for 2 minutes to sterilize.

1.2 In a biosafety cabinet, isolate femurs and tibias, removing excess muscle tissue. Trim only 0.5 mm from bone ends to preserve marrow.

1.3 Flush the marrow cavity with sterile PBS using a syringe until bones turn white. Keep samples on ice.

1.4 Filter the suspension through a 70 μm strainer, centrifuge at 500 × g for 5 minutes, and discard supernatant.

1.5 Resuspend the pellet in ACK lysis buffer to remove red blood cells, centrifuge at 200 × g for 5 minutes, and discard supernatant.

1.6 Seed cells at 5 × 10⁵ cells/mL in DMEM with 10% FBS, 1% Pen-Strep, and 10 ng/mL M-CSF.

2. Macrophage Polarization Induction

2.1 Differentiation: Perform half-medium changes every other day with fresh M-CSF medium. After 6–7 days, cells become M0 macrophages.

2.2 M1 Polarization: Add 100 ng/mL LPS and 50 ng/mL IFN-γ to M0 cultures. Incubate for 24–48 hours.

2.3 M2 Polarization: Add 40 ng/mL IL-4 and/or 40 ng/mL IL-13 to M0 cultures. Incubate for 24–48 hours.

3. Macrophage Identification

M0: Flow cytometry for F4/80+ and CD11b+.

M1: Flow cytometry for upregulated CD86, MHC II, and CD11c.

M2: Flow cytometry for upregulated CD206.

4. Experimental Case Data

Figure 3. Flow cytometry scatter plots of M1/M2 polarization. Data provided by The Second Affiliated Hospital of Wenzhou Medical University

Related Products

Product Category	Catalog Number	Product Name
Cytokines	92643ES	Mouse Macrophage BMDM Cytokine Set
Cell Culture	41401ES	DMEM High Glucose Medium (with L-glutamine, sodium pyruvate 110 mg/L; without HEPES and antibiotics)
Cell Culture	41403ES	1× PBS, Cell Culture Grade
Cell Culture	60162ES	Penicillin-Streptomycin (100×), Suitable for Cell Culture

References

Ernestina A, Marcarious M T, Rui Z, et al. Exploring the polarization of M1 and M2 macrophages in the context of skin diseases. Mol Biol Rep. 2024 Feb 1;51(1):269.